Description
THIS BILATERAL MODIFICATION IS ISSUED TO TERMINATE NATIONAL CONTRACT 36E79722D0017. THE TERMINATION FOR CONVENIENCE TO THE GOVERNMENT IS EFFECTIVE OCTOBER 15, 2023. (MAJOR PHARM 236E79722D0017)
Base award description: NEW AWARD FOR TAMSULOSIN CAPSULES WITH THE HARVARD DRUG GROUP, L.L.C. DBA MAJOR PHARMACEUTICALS AND RUGBY LABORATORIES. PERIOD OF PERFORMANCE IS JUN 1, 2022 TO MAY 31, 2023 WITH FOUR ONE-YEAR OPTIONS.
Modification chain · 6 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-03-07+$0= $0
- Mod P000012022-06-28+$0= $0
- Mod P000022023-04-24+$0= $0
- Mod P000032023-04-25+$0= $0
- Mod P000042023-06-14+$0= $0
- Mod P000052023-09-26+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-03-07 | +$0 | $0 | NEW AWARD FOR TAMSULOSIN CAPSULES WITH THE HARVARD DRUG GROUP, L.L.C. DBA MAJOR PHARMACEUTICALS AND RUGBY LABO… |
| Mod P00001· ADD SUBCONTRACTING PLAN | 2022-06-28 | +$0 | $0 | THE HARVARD DRUG GROUP, L.L.C. DBA MAJOR PHARMACEUTICALS & RUGBY LABORATORIES 2022 SUBCONTRACTING PLAN. THIS M… |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2023-04-24 | +$0 | $0 | INCORPORATION OF DRUG SUPPLY CHAIN SECURITY ACT (DSCSA) LANGUAGE |
| Mod P00003· EXERCISE AN OPTION | 2023-04-25 | +$0 | $0 | EXERCISE OPTION YEAR 1 FOR TAMSULOSIN CAPSULES WITH THE HARVARD DRUG GROUP, L.L.C. DBA MAJOR PHARMACEUTICALS A… |
| Mod P00004· ADD SUBCONTRACTING PLAN | 2023-06-14 | +$0 | $0 | THE HARVARD DRUG GROUP, LLC DBA MAJOR PHARMACEUTICALS & RUGBY LABORATORIES 2023 SUBCONTRACTING PLAN. INCORPORA… |
| Mod P00005· TERMINATE FOR CONVENIENCE (COMPLETE OR PARTIAL) | 2023-09-26 | +$0 | $0 | THIS BILATERAL MODIFICATION IS ISSUED TO TERMINATE NATIONAL CONTRACT 36E79722D0017. THE TERMINATION FOR CONVEN… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CBGGKKVNJBK9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36F79725D0121 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36E79725D0010 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36E79725D0001 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36E79721D0048 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2021 |
| 36E79721D0038 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2021 |
| 36F79719D0033 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2019 |
Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36E79726A0025 | CHIESI USA INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0024 | NEUROTECH PHARMACEUTICALS, INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0023 | TAKEDA PHARMACEUTICALS AMERICA, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726D0041 | GOLDEN STATE MEDICAL SUPPLY, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0022 | AURINIA PHARMA US INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79722D0017_3600 · retrieved 2026-09-26.